News Sentiment

RAPP sentiment intelligence

Rapport Therapeutics, Inc. Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 74 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 41.75 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

80/100 classification confidence.

Company focus 67

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend active

+7.1% over one week, +8.7% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Rapport Therapeutics CEO Ceesay Abraham sells $328,436 in stock By Investing.com

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 80/100 classification
One-week reaction 7.1% Price confirming higher
Trend fit Trend active 8.7% over four weeks
Fair value 85.2% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 24
Neutral 44
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 67
Industry context 7
Sector context 0

Sources

Coverage mix

Publishers
Market source 10
TradingView 5
Stock Titan 5
TradingKey 5
Investing.com 3
Stock Traders Daily 3
Quartr 3
marketscreener.com 3

Event Lens

What the news is about

Classified themes
Market update 41
Earnings 21
Analyst action 6
Balance sheet 3
Capital return 1
Deals and strategy 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 74
TradingKey Direct company coverage

Rapport Therapeutics Inc (RAPP) Financial Health: Profitability & Balance Sheet Analysis

This article analyzes the financial health of Rapport Therapeutics Inc (RAPP), focusing on its profitability and balance sheet. While the company's stock price, market cap, and P/E ratio are provided, the detailed financial metrics for cash and cash equivalents, total assets, lia

Tone
Neutral 50/100
Event
Balance sheet
Published
18 Jun 2026 06:10
Source
TradingKey
TradingKey Direct company coverage

Rapport Therapeutics Inc (RAPP) Institutional Confidence

This article examines the institutional confidence in Rapport Therapeutics Inc (RAPP) by presenting a table of major institutional shareholders and their shareholdings. Key investors like Third Rock Ventures, Fidelity Management & Research Company, and ARCH Venture Partners are l

Tone
Positive 71/100
Event
Market update
Published
18 Jun 2026 00:09
Source
TradingKey